MNDL Bio
Optimization of Gene Expression using Computational Approaches
Active
Pre-Seed
Startup
Herzliya
Founded 2023-06
MNDL Bio's solution focuses on optimizing gene expression in cells to significantly increase protein production yield. Leveraging cutting-edge technology, including advanced algorithms and patented methods, the core technology utilizes Artificial Intelligence (AI) and Machine Learning (ML) based on genomic Big Data. MNDL enhances the efficiency of biologica…
SectorHealth Tech & Life Sciences
StagePre-Seed
Total raised$2.1M
Employees8
Founded2023-06
HQHerzliya
Patents1
Confidence89
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringClimate TechClean Industry Tech Sustainable Materials & Circularity
Technology
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsIndustrial ManufacturingProcess IndustriesPlastics